In this grant a murine model of lymphoproliferation will be analyzed to determine the molecular events involved in the clonal expansion of B-1 cells. The NZB strain develops clones of B-1 cells and is a model of chronic lymphocytic leukemia (CLL). Three different types of B-1 expanded populations will be studied: (1) pre-CLL in which the B-1 cells are expanded and several slow growing clones may be present, these appear in normal and (NZB, X DBA /2)Fl mice as late-appearing clones (2) CLL-like in which clonal expansion occurs and hyperdiploid B-1 clones develop which are non-aggressive, and (3) the expression of an aggressive invasive neoplasia of B-1 cells similar to that seen in Richter's. These three separate types of B-1 cells will be examined for both shared and unique characteristics which may be responsible for the clonal expansion. The B-1 clones will be analyzed for the ability to undergo apoptosis, a feature of fetal pre-B cells and a possible mechanism for the deletion of self-reactive cells and cells incapable of responding to a specific antigen. The possibility that apoptosis is increased in the early appearing B-1 hyperdiploid clones which develop into aggressive neoplasias and absent from the late appearing slow-growing clones may allow the possible use of apoptosis induction in the regulation of the growth of these neoplasias. The immunoglobulin sequence of the B-1 clones both early and late appearing will be studied. It is hypothesized that the neoplastic clones are similar to fetal B cells in the CDR3 region with very little N base substitutions. Molecular modeling studies will help to determine if developmental restrictions in the CDR3 region result in a unique binding site for the early appearing B-1 clones. Other characteristics of fetal B cells will be studied in the B-1 clones such as lambda 5 gene expression and cytokine expression. The role of IL-10 levels in both the development of B-1 neoplasias and the induction of apoptosis will be studied. Preliminary results have indicated that NZB mice that live nearly twice as long as the average life-span do not develop hyperdiploid B-1 malignancies but rather display T cell expansions. The cytokine profiles of these T cell clones will be studied as well as in vivo transfers of these T cells to determine the possible therapeutic role of T cells in the prevention of B-1 neoplasias. Finally, the genes responsible for the development of hyperdiploid B-1 clones will be investigated at a molecular level by two different techniques. The first technique will look for genetic polymorphisms in F2 and backcross animals which are linked to the expression of hyperdiploid B-1 clones. Another technique will use an mRNA subtraction library made up of the differences between slow and fast growing B-1 malignancies. The ultimate goal is to identify in the lymphoproliferative condition the genes responsible for the uncontrolled clonal expansion of B-1 neoplasias.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029740-05
Application #
2065193
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1989-09-30
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
07107
Dang, A M; Phillips, J A; Lin, T et al. (1996) Altered CD45 expression in malignant B-1 cells. Cell Immunol 169:196-207
Ende, N; Czarneski, J; Raveche, E (1995) Effect of human cord blood transfer on survival and disease activity in MRL-lpr/lpr mice. Clin Immunol Immunopathol 75:190-5
Peng, B; Mehta, N H; Fernandes, H et al. (1995) Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leuk Res 19:159-67
Peng, B; Sherr, D H; Mahboudi, F et al. (1994) A cultured malignant B-1 line serves as a model for Richter's syndrome. J Immunol 153:1869-80
Peng, B; Raveche, E (1993) Apoptosis induction in CD5+(Ly1+) malignant B cells. Leukemia 7:789-94
Lin, T Z; Fernandes, H; Yauch, R et al. (1992) IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse. Clin Immunol Immunopathol 65:10-22
Phillips, J A; Mehta, K; Fernandez, C et al. (1992) The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res 52:437-43
Raveche, E S; Tjio, J H (1991) Hyperdiploid-CD5-positive B cells in mouse. Int J Hematol 54:25-35
Raveche, E S; Lin, T Z; Conroy, J et al. (1991) Influence of host environment on growth of clonal CD5+B (Lyl+B) cells. Autoimmunity 10:217-25
Raveche, E S (1990) Possible immunoregulatory role for CD5 + B cells. Clin Immunol Immunopathol 56:135-50

Showing the most recent 10 out of 11 publications